It’s an honour to represent the very best that molecular imaging has to offer as President-elect for the European Society for Molecular Imaging. I’ve been fortunate enough to have been actively involved with the society for the last decade, where we have seen tremendous growth in membership, attendees at our EMIM meeting, and the variety of different imaging approaches being explored. We have done this whilst maintaining a special community spirit that is unique to ESMI. I can’t wait to work with the senior leadership team to increase opportunities for our members, especially our more junior scientists, and raise the profile of your excellent work. Thank you for giving me the opportunity of a lifetime.
Professor Tim Witney, Vice President and incoming President elect of ESMI
05 March 2025
Professor Tim Witney elected Vice President of ESMI
Professor Tim Witney, Wellcome Trust Senior Research Fellow and Professor of Molecular Imaging at the School of Biomedical Engineering & Imaging Sciences, has been elected the Vice President of the European Society for Molecular Imaging (ESMI), and will take up the role of President in 2026.
The ESMI is the largest scientific society for molecular imaging in Europe, bringing together researchers working across disciplines to advance imaging technologies, methodologies, and their clinical translation, with an annual meeting of approximately 1200 people.
The society fosters collaboration, supports early-career scientists, and plays a key role in shaping the future of imaging science, and Professor Witney's appointment recognizes his contributions to the field and his leadership within the international molecular imaging community.
Following his election, Professor Witney will continue to serve on the ESMI Executive Committee and is set to become President of the Society from March 2026 to 2027. His leadership will guide the society in its mission to push the boundaries of molecular imaging and its impact on biomedical research and patient care.
At King's, Professor Witney leads the Witney Lab, where his team develops cutting-edge positron emission tomography (PET) imaging techniques to study tumour biochemistry in vivo. His work focuses on understanding how these novel imaging approaches can help predict tumour response to therapy, with the ultimate aim of improving cancer treatment and patient outcomes.
In this story
Professor of Molecular Imaging